Abrocitinib: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

1 February 2024

  • curprev 01:4901:49, 1 February 2024‎ Edzelco talk contribs‎ 37,082 bytes +604‎ No edit summary
  • curprev 01:4601:46, 1 February 2024‎ Edzelco talk contribs‎ 36,478 bytes +13,636‎ No edit summary
  • curprev 01:3101:31, 1 February 2024‎ Edzelco talk contribs‎ 22,842 bytes +22,842‎ Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |indicationType=treatment |indication=adults and pediatric patients 12 years of age and older with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies is inadvisable. |blackBoxWarningTitle=WARNING: SERIOUS INFECTIONS, MORTALITY, MALIGNANCY, MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE), and THROMBOS..."
Retrieved from "https://www.wikidoc.org/index.php/Abrocitinib"